Literature DB >> 28708810

Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients.

Andrea Calcagno1, Stefania Piconi, Emanuele Focà, Silvia Nozza, Federica Carli, Chiara Montrucchio, Annamaria M Cattelan, Giancarlo Orofino, Benedetto M Celesia, Valentina Morena, Giuseppe V De Socio, Giovanni Guaraldi.   

Abstract

BACKGROUND: Adults aging with HIV are at greater risk for several comorbidities. The CD4 cell count and CD4/CD8 ratio often fail to normalize in elderly patients despite prolonged antiretroviral therapy; this has been associated with concomitant diseases and poor prognosis.
METHODS: A cross-sectional analysis in antiretroviral-treated HIV-positive patients aged 65 years and older. The aim of the study was to describe the predictors of normalized T-cell subsets ("nT", CD4/CD8 ratio ≥1 and CD4 ≥500 cells/μL) in a cohort of geriatric HIV-positive patients and its association with HIV-associated non-AIDS conditions (HANA).
RESULTS: One thousand ninety-two patients were included: nT was observed in 340 patients (31.1%). Multivariate binary logistic analysis showed that plasma HIV RNA <50 copies/mL (P = 0.004), female sex (P = 0.002), and nadir CD4 cell count (P < 0.001) were independent predictors of nT. Age and sex-adjusted prevalence of hypertension (P = 0.037), lipid abnormalities (P = 0.040), and multimorbidity (P = 0.034) were higher in subjects with nT, whereas chronic obstructive pulmonary disease (COPD) and cancer were lower (respectively, P = 0.028 and P = 0.005). Multivariate analysis showed that HIV duration was an independent predictor of several comorbidities, whereas nT was protective for cancer and COPD. HIV duration and nT were simultaneously predictors of multimorbidity.
CONCLUSIONS: Normalized T-cell subsets were observed in approximately one-third of geriatric HIV-positive subjects, and they were predicted by female sex and immunovirological features. HIV-associated non-AIDS conditions were more prevalent in patients with longer HIV duration, whereas nT represented a protective factor for cancer and COPD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28708810     DOI: 10.1097/QAI.0000000000001496

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  4 in total

1.  Factors Associated With Progression of Lung Function Abnormalities in HIV-Infected Individuals.

Authors:  Yijia Li; Seyed Mehdi Nouraie; Cathy Kessinger; Renee Weinman; Laurence Huang; Ruth M Greenblatt; Eric Kleerup; Lawrence Kingsley; Deborah McMahon; Meghan Fitzpatrick; Alison Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

2.  Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region.

Authors:  Simona Cammarota; Anna Citarella; Lamberto Manzoli; Maria Elena Flacco; Giustino Parruti
Journal:  Clinicoecon Outcomes Res       Date:  2018-07-23

3.  Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.

Authors:  Emanuele Focà; Paola Magro; Giovanni Guaraldi; Agostino Riva; Anna Maria Cattelan; Giuseppe Vittorio De Socio; Cecilia Costa; Stefania Piconi; Benedetto Maurizio Celesia; Silvia Nozza; Giancarlo Orofino; Antonella Castagna; Giovanni Di Perri; Francesco Castelli; Andrea Calcagno
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

4.  Pilot study assessing the Rotterdam Healthy Aging Score in a cohort of HIV-positive adults in Toronto, Canada.

Authors:  Sharon L Walmsley; Melody Ren; Ceylon Simon; Rosemarie Clarke; Leah Szadkowski
Journal:  AIDS       Date:  2020-05-01       Impact factor: 4.632

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.